MILDRONATE THERAPY IN PATIENTS WITH CHRONIC HEART FAILURE, TYPE 2 DIABETES MELLITUS AND AUTONOMOUS CARDIAC NEUROPATHY

QR Code

MILDRONATE THERAPY IN PATIENTS WITH CHRONIC HEART FAILURE, TYPE 2 DIABETES MELLITUS AND AUTONOMOUS CARDIAC NEUROPATHY

In total, 60 45-70-year-old patients with Functional Class II-III chronic heart failure (CHF) after a myocardial infarction, compensated or sub-compensated Type 2 diabetes mellitus (DM-2), and autonomous cardiac neuropathy were examined. The basis therapy included enalapril, bisoprolol, aspirin, and...

Full description

Saved in:

Bibliographic Details
Main Authors:	M. E. Statsenko, S. V. Turkina, S. V. Belenkova
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2009-06-01
Series:	Российский кардиологический журнал
Subjects:	chronic heart failure type 2 diabetes mellitus autonomous cardiac neuropathy mildronate
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/1357
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

EFFECTS OF MILDRONATE, AS A PART OF COMBINED HEART FAILURE THERAPY, ON CARBOHYDRATE AND LIPID METABOLISM AND OXIDATIVE STRESS PARAMETERS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
by: M. E. Statsenko, et al.
Published: (2010-04-01)

DIAGNOSTIC VALUE OF SPECTRAL ANALYSIS OF HEART RATE VARIABILITY IN CARDIAC AUTONOMIC NEUROPATHY AND TYPE 2 DIABETES MELLITUS
by: E. Yu. Lunina, et al.
Published: (2012-06-01)

Changes in left ventricular structure and function in Type 2 diabetic patients, depending on the presence of cardiac autonomic neuropathy and metabolic syndrome components
by: E. Yu. Lunina, et al.
Published: (1970-01-01)

Effects of benfotiamine on the insulin resistance state, some pro- and anti-inflammatory factors content in patients with type 2 diabetes mellitus and cardiac autonomic neuropathy
by: V. A. Serhiyenko, et al.
Published: (2019-05-01)

EFFECTS OF OMEGA-3 POLYUNSATURATED FATTY ACIDS ON THE CIRCADIAN RHYTHM OF HEART RATE VARIABILITY PARAMETERS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND CARDIOVASCULAR AUTONOMIC NEUROPATHY
by: V. A. Serhiyenko, et al.
Published: (2018-06-01)

Endothelial dysfunction in heart failure with normal systolic function, and its correction with a metabolic agent, mildronate
by: V. P. Geychenko, et al.
Published: (2005-08-01)

MILDRONATE EFFECT ON ENDOTHELIUM-DEPENDENT VASODILATION IN PATIENTS WITH CHRONIC HEART FAILURE: DOUBLE BLIND CROSSOVER STUDY
by: L. G. Voronkov, et al.
Published: (2016-01-01)

Association of Different Types of Diabetic Autonomic Neuropathy With Left Ventricular Diastolic Dysfunction in Patients With Type 2 Diabetes: A Cross‐Sectional Study
by: Ruixue Feng, et al.
Published: (2025-07-01)

MILDRONATE POTENTIAL FOR CORRECTING COGNITIVE DYSFUNCTION IN ELDERLY PATIENTS WITH ARTERIAL HYPERTENSION
by: M. E. Statsenko, et al.
Published: (2011-08-01)

Coherence Analysis of Cardiovascular Signals for Detecting Early Diabetic Cardiac Autonomic Neuropathy: Insights into Glycemic Control
by: Yu-Chen Chen, et al.
Published: (2025-06-01)

MILDRONATE POTENTIAL FOR CARDIAC ARRHYTHMIA PREVENTION IN PERIOPERATIVE PERIODcardiac arrhythmias, ischemia, metabolic disturbances, cytoprotectors, antioxidants, operation-related stress, general anesthesia, Mildronate
by: V. P. Mikhin, et al.
Published: (2014-02-01)

Diabetic distress, low-grade chronic inflammation, and cardiac autonomic neuropathy in internally displaced people (literature review and own observations)
by: V.A. Serhiyenkо
Published: (2025-06-01)

ДИАБЕТИЧЕСКАЯ АВТОНОМНАЯ КАРД ИАЛЬНАЯ НЕЙРОПАТИЯ У БОЛЬНЫХ САХАРНЫМ ДИАБЕТОМ 2 ТИПА: ФОКУС НА НЕРЕШЁННЫЕ ПРОБЛЕМЫ
by: М. Е. Стаценко, et al.
Published: (2013-06-01)

Mildronate effects on cognitive function in elderly patients with arterial hypertension
by: S. V. Nedogoda, et al.
Published: (2012-10-01)

Mildronate in cardiology practice – current evidence, ongoing research, and future perspectives
by: V. P. Mikhin, et al.
Published: (2012-02-01)

DISORDERS OF THE AUTONOMIC NERVOUS SYSTEM IN THE CARDIOLOGY PRACTICE: FOCUS ON THE ANALYSIS OF HEART RATE VARIABILITY
by: E. B. Akhmedova, et al.
Published: (2015-09-01)

A Prospective Study of the Correlation Between Time in Range and Incidence of Diabetic Cardiovascular Autonomic Neuropathy in Patients with Type 2 Diabetes Mellitus
by: Shan X, et al.
Published: (2025-07-01)

High Diagnostic Performance of the Indicator Plaster Neuropad for the Detection of Established Diabetic Autonomic Neuropathy
by: Ioanna Zografou, et al.
Published: (2025-06-01)

Features of short-term heart rate variability in internally displaced people with type 2 diabetes mellitus
by: V.A. Serhiyenko, et al.
Published: (2025-05-01)

DIABETES MELLITUS 2ND TYPE WITH CARDIOVASCULAR AUTONOMIC NEUROPATHY
by: V. A. Serhiyenko, et al.
Published: (2015-09-01)

PHARMACOTHERAPY POSSIBILITIES OF CARDIOVASCULAR AUTONOMOUS NEUROPATHY IN CHILDREN WITH TYPE 1 DIABETES MELLITUS AT THE PRECLINICAL STAGE
by: N. V. Malyuzhinskaya, et al.
Published: (2022-03-01)

NEW POTENTIAL OF PHARMACEUTICAL CORRECTION OF CARDIAC AUTONOMIC NEUROPATHY IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND CHRONIC HEART FAILURE
by: M. E. Statsenko, et al.
Published: (2011-10-01)

MEXICOR IN THE COMBINATION THERAPY OF CHRONIC HEART FAILURE AND TYPE 2 DIABETES MELLITUS
by: M. E. Statsenko, et al.
Published: (2011-12-01)

Severe hypertriglyceridaemia with length-related small fibre sensory neuropathy as a complication of previous gestational diabetes mellitus
by: Fatima Iqbal, et al.
Published: (2025-07-01)

INFLUENCE OF MILDRONATE ON EFFICIENCY OF ANTIANGINAL THERAPY IN PATIENTS WITH STABLE BURDEN ANGINA
by: N. P. Kutishenko, et al.
Published: (2015-12-01)

Diabetes mellitus and cardiac arrhythmias
by: L. Yu. Morgunov
Published: (2024-04-01)

Corneal Sensitivity as a Potential Marker of Diabetic Neuropathy
by: Ratna Sitompul
Published: (2017-08-01)

Corneal Sensitivity as a Potential Marker of Diabetic Neuropathy
by: Ratna Sitompul
Published: (2017-08-01)

Mildronate effectiveness in post-hospital rehabilitation of patients with myocardial infarction
by: V. P. Mikhin, et al.
Published: (2012-04-01)

CYTOPROTECTOR MILDRONATE IN CORRECTING MYOCARDIAL DYSFUNCTION AMONG STABLE ANGINA PATIENTS AFTER CORONARY REVASCULARISATION
by: I. G. Gordeev, et al.
Published: (2009-04-01)

ANTIOXIDANT EFFECT OF MILDRONATE IN PATIENTS AFTER CORONARY REVASCULARISATION
by: I. G. Gordeev, et al.
Published: (2009-02-01)

SIGNIFICANCE OF HEART RHYTHM VARIABILITY IN RHEUMATOID ARTHRITIS
by: E. V. Udachkina, et al.
Published: (2016-02-01)

THE ASSESSMENT OF EFFECTS OF COMBINED THERAPY WITH MILDRONATE ON LIPID PROFILE, INFLAMMATORY FACTORS AND ENDOTHELIUM FUNCTION IN PATIENTS WITH ISCHEMIC HEART DISEASE
by: I. V. Sergienko, et al.
Published: (2015-12-01)

The treatment of the chronic cardiac failure in patients with type 2 diabetes mellitus in clinical practice
by: T. Yu. Lityaeva
Published: (2011-08-01)

The Correlation Between HbA1c and Neuropathy Disability Score in Type 2 Diabetes
by: Ilsa Hunaifi, et al.
Published: (2021-07-01)

Sudomotor Dysfunction as an Early Marker of Autonomic and Cardiovascular Risk in Diabetes: Insights from a Cross-Sectional Study Using SUDOSCAN
by: Larisa Anghel, et al.
Published: (2025-06-01)

Comparison of inflammatory markers and nerve conduction studies in prediabetes and type two diabetes mellitus: A possible role in neuropathy
by: Zarghuna Khan, et al.
Published: (2025-06-01)

Systemic Amyloidosis with Cardiac Involvement: Features of Course and Diagnostic Difficulties
by: E. V. Voloshinova, et al.
Published: (2024-08-01)

COMPARISON OF CARVEDILOL AND BISOPROLOL EFFICACY IN PATIENTS WITH CHRONIC HEART FAILURE AND DIABETES TYPES 2 AFTER MYOCARDIAL INFARCTION
by: M. E. Statsenko, et al.
Published: (2016-01-01)

Lesions of the nervous system in children with type 1 diabetes mellitus (literature review)
by: E. V. Mukhina, et al.
Published: (2019-05-01)